Guardant Health
GH
#1349
Rank
โ‚น1.581 T
Marketcap
โ‚น11,927
Share price
-5.60%
Change (1 day)
189.28%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -โ‚น303.54

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น321.88. In 2025 the company made an earnings per share (EPS) of -โ‚น314.28 an increase over its 2024 EPS that were of -โ‚น338.02.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น303.54-3.42%
2025-โ‚น314.28-7.02%
2024-โ‚น338.02-16.82%
2023-โ‚น406.39-33.13%
2022-โ‚น607.6860%
2021-โ‚น379.8055.04%
2020-โ‚น244.97207.14%
2019-โ‚น79.76-19.81%
2018-โ‚น99.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-โ‚น266.48-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น235.48-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA